Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21587844 | 0.81 | RAB9A (0.30) | — | |
| SCHEMBL21585752 | 0.71 | DAO (0.37) | — | |
| SCHEMBL22544605 | 0.65 | POLB (0.46) | — | |
| SCHEMBL22847692 | 0.64 | NPC1 (0.40) | — | |
| SCHEMBL8377155 | 0.61 | NTRK1 (0.35) | — | |
| SCHEMBL22544466 | 0.61 | POLB (0.46) | — | |
| SCHEMBL25972032 | 0.61 | AURKA (0.42) | — | |
| SCHEMBL16742700 | 0.61 | MARS1 (0.49) | — | |
| SCHEMBL8940963 | 0.61 | — | — | |
| SCHEMBL8377149 | 0.58 | MAPT (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210323950-A1 | HERBICIDALLY ACTIVE BICYCLIC BENZOYLPYRAZOLES | BAYER AG (DE) | 2021-10-21 | — | — | US | disclosed |
| EP-3802521-A1 | HERBICIDALLY ACTIVE BICYCLIC BENZOYLPYRAZOLES | Bayer Aktiengesellschaft (DE) | 2021-04-14 | — | — | EP | disclosed |
| CN-112513033-A | Herbicidally active bicyclic benzoylpyrazoles | 拜耳公司 | 2021-03-16 | — | — | CN | disclosed |
| WO-2019233863-A1 | HERBICIDALLY ACTIVE BICYCLIC BENZOYLPYRAZOLES | BAYER AKTIENGESELLSCHAFT (DE) | 2019-12-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210323950-A1 | HERBICIDALLY ACTIVE BICYCLIC BENZOYLPYRAZOLES | CBR3, CBR1, RTN3 | PTGDR2 963/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.